These Stocks Are Moving the Most Today: Metsera, Nvidia, Tesla, Rumble, MP Materials, ViaSat, Monday.com, CoreWeave, and More

Stocks gained Monday, with the S&P 500 and Nasdaq Composite each rising over 1%, as investors remained hopeful that the ...

Metsera falls after accepting up to $10 billion sweetened buyout offer from Pfizer

Shares of Metsera fell over 15% in premarket trading on Monday, after the weight-loss drug developer accepted a sweetened ...
BioSpace

Pfizer’s Winning Bid For Metsera Concludes ‘Real Housewives of Biopharma’

“No need for a reunion show: This seasons Real Housewives of Biopharma comes to a close with Pfizer’s winning bid for Metsera ...

Pfizer's move for Metsera adds to busy year of healthcare M&A. But the sector's in a rut.

Pfizer's agreement to buy Metsera just adds to the 83 healthcare deals counted by Goldman Sachs that were above $100 million ...
PharmExec

Novo Nordisk Not Planning Increased Proposal Offer After Metsera Enters $10 Billion Amended Merger Agreement with Pfizer

On November 4, 2025, just a day after Pfizer filed its suits against Novo Nordisk and Metsera, Novo Nordisk submitted an ...

Monday.Com, Metsera, Profrac Holding And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Metsera Inc (NASDAQ: MTSR) shares dipped 15% to $70.68 in pre-market trading. Pfizer Inc. (NYSE: PFE) secured a $10 billion ...

Metsera Shares Fall Premarket as Novo Throws in Towel on Bidding War

Metsera shares fell sharply in premarket trading Monday after the weight-loss drug startup struck a revised deal to be acquired by Pfizer, prompting Danish drugmaker Novo Nordisk to drop out of a ...

Pfizer Gets Metsera: Why The $20.65 CVR Is Highly Likely To Pay Out (In Part)

Pfizer Inc. acquires Metsera, Inc., beating Novo Nordisk, for up to $86.25/share. Click for my analysis of the deal and what ...